✦ LIBER ✦

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study

✍ Scribed by Lamiaa Boulaamane; Saber Boutayeb; Hassan Errihani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab plus chemotherapy as first-l

✍ Stein, Alexander; Petersen, Volker; Schulze, Mathias; Seraphin, Jörg; Hoeffkes, 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 406 KB

Phase II Study of Gemcitabine and Bevaci

✍ Rachel Borson; Graydon Harker; James Reeves; Thaddeus Beck; Steven Hager; Willia 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 387 KB

Biomarker results from the AVADO phase 3

✍ Miles, D W; de Haas, S L; Dirix, L Y; Romieu, G; Chan, A; Pivot, X; Tomczak, P; 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 366 KB

First-line bevacizumab in combination wi

✍ Miles, D. W.; Dieras, V.; Cortes, J.; Duenne, A.- A.; Yi, J.; O'Shaughnessy, J. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 426 KB

A multicenter phase I–II study of doceta

✍ Tryfonidis, K.; Boukovinas, I.; Xenidis, N.; Christophyllakis, C.; Papakotoulas, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 348 KB

Final results of a phase II study ofnab-

✍ Christopher Lobo; Gilberto Lopes; Odalys Baez; Aurelio Castrellon; Annapoorna Fe 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 268 KB